Articles
Short notes on repeat FDA patterns.
Source-backed notes for readers who want the enforcement pattern before opening the source record.
FDA's GLP-1 compounding crackdown
What FDA's public GLP-1 concerns mean for compounders, clinics, patients, and anyone tracking quality risk in the weight-loss drug supply chain.
OTC drug CGMP warning-letter patterns
Why manufacturing controls, lab controls, and quality-unit oversight keep showing up in recent public letters.
Device software and cyber recall signals
A practical way to read software maintenance releases and cyber vulnerability recall language.